First photochromic lens approved in Europe

Medennium has obtained CE mark clearance to market its photochromic intraocular lens (IOL), Aurium in Europe, making it the first lens of its kind to be introduced to the cataract lens market.

Medennium has obtained CE mark clearance to market its photochromic intraocular lens (IOL), Aurium in Europe, making it the first lens of its kind to be introduced to the cataract lens market.

As part of the approval process, clinical data from two sites were examined. Fifteen patients received the lens in one eye and a controlled IOL with yellow colour in the fellow eye. At six-months follow-up the Arium lenses offered better best corrected visual acuity (BCVA) than the control lens, especially under weak light conditions.

Medennium will initially launch the lens in selected European countries and it hopes that by September of this year it should be available to all European cataract surgeons.

Related Videos
Trukera Medical rebranding ushers in new era of expansion into cornea market
Investigators report positive visual outcomes one year after monocular implantation of small aperture IOL
Investigating better indications and outcomes in laser refractive surgery
Avoiding errors when converting to DMEK
EDOF lens tech is evolving to help more patients with intermediate vision
Fixoflex ring: Prof. Pallikaris describes how to utilise the device during IOL implantation
Related Content
© 2023 MJH Life Sciences

All rights reserved.